EyePoint (EYPT) Shares Outstanding (2010 - 2026)
EyePoint (EYPT) posted Shares Outstanding (Entity) of $85999.0 for Q1 2026, up 17.4% sequentially from $73251.0 in Q4 2025, and down 99.88% YoY from $68.8 million in Q1 2025.
EyePoint (EYPT) Shares Outstanding (2010 - 2026) Analysis & Trends
EyePoint has reported Shares Outstanding (Entity) for 17 years, with the latest figure at $85999.0 in Q1 2026.
- Quarterly Shares Outstanding (Entity) fell 99.88% year-over-year to $85999.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $85999.0 (down 99.88% YoY) and the FY2025 annual result came in at $73251.0, up 30.11% from the prior year.
- Shares Outstanding (Entity) rose to $85999.0 in Q1 2026 per EYPT's latest filing, from $73251.0 in the prior quarter.
- Over five years, Shares Outstanding (Entity) peaked at $68.8 million in Q1 2025 and troughed at $52913.0 in Q1 2024.
- A 5-year average of $26.7 million and a median of $34.1 million in 2022 frame the typical range for Shares Outstanding (Entity).
- The sharpest annual moves came in 2025 and 2026: Shares Outstanding (Entity) surged 129946.22% in 2025, then plunged 99.88% in 2026.
- Over 5 years, Shares Outstanding (Entity) stood at $34.1 million in 2022, then gained by 14.15% to $38.9 million in 2023, then tumbled by 99.86% to $56298.0 in 2024, then surged by 30.11% to $73251.0 in 2025, then climbed by 17.4% to $85999.0 in 2026.
- According to Business Quant data, Shares Outstanding (Entity) over the past three periods registered $85999.0, $73251.0, and $70168.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 253.70 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 102.80 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 62.19 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 210.89 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.45 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 25.05 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 445.06 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 133.61 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 217.35 Mn |
| 10 | EyePoint | 1.25 Bn | 1.07 Bn | 507,000.00 | 86.54 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 86,543.00 |
| Mar 31, 2026 | 85,999.00 |
| Dec 31, 2025 | 73,251.00 |
| Sep 30, 2025 | 70,168.00 |
| Jun 30, 2025 | 69,926.00 |
| Mar 31, 2025 | 69.77 Mn |
| Dec 31, 2024 | 56,298.00 |
| Sep 30, 2024 | 54.45 Mn |
| Jun 30, 2024 | 53.21 Mn |
| Mar 31, 2024 | 52,913.00 |
| Dec 31, 2023 | 38.90 Mn |
| Sep 30, 2023 | 38.34 Mn |
| Jun 30, 2023 | 37.58 Mn |
| Mar 31, 2023 | 37.49 Mn |
| Dec 31, 2022 | 37.32 Mn |
| Sep 30, 2022 | 37.34 Mn |
| Jun 30, 2022 | 37.32 Mn |
| Mar 31, 2022 | 37.25 Mn |
| Dec 31, 2021 | 28.76 Mn |
| Sep 30, 2021 | 28.77 Mn |